Overactive Bladder - Results from #1960

Prospective study of prevalence of overactive bladder symptoms and child-bearing in women of reproductive age - Abstract July 2, 2013

Reliability and validity of the overactive bladder symptom score in Hong Kong Chinese - Abstract July 2, 2013

A phase III, randomized, double-blind, parallel-group, placebo-controlled, multicentre study to assess the efficacy and safety of the β(3) adrenoceptor agonist, mirabegron, in patients with symptoms of overactive bladder - Abstract June 28, 2013

Validation of the Spanish version of the questionnaire "Benefit, Satisfaction and Willingness to Continue the Treatment" in patients with overactive bladder - Abstract June 28, 2013

The prevalence and risk factors of OAB in middle-aged and old people in China - Abstract June 26, 2013

Efficacy and safety of repeated dosing of netupitant, a neurokinin-1 receptor antagonist, in treating overactive bladder - Abstract June 25, 2013

Adherence, persistence and switch rates for anticholinergic drugs used for overactive bladder in women: Data from the Norwegian Prescription database - Abstract June 25, 2013

Pharmacokinetics of intravesical versus oral oxybutynin in healthy adults: Results of an open-label, randomized prospective clinical study - Abstract June 24, 2013

Mirabegron: β3-adrenergic receptor agonist for the treatment of overactive bladder - Abstract June 21, 2013

Management of lower urinary tract dysfunction in multiple sclerosis: A systematic review and Turkish consensus report - Abstract June 21, 2013

Prospective and randomized comparison of electrical stimulation of the posterior tibial nerve versus oxybutynin versus their combination for treatment of women with overactive bladder syndrome - Abstract June 19, 2013

Psychometric performance of the Incontinence Quality-of-Life Questionnaire among patients with overactive bladder and urinary incontinence - Abstract June 19, 2013

Urinary ATP may be a dynamic biomarker of detrusor overactivity in women with overactive bladder syndrome - Abstract June 17, 2013

Lipid-based intravesical drug delivery systems with controlled release of trospium chloride for the urinary bladder - Abstract June 14, 2013

Neurogenic detrusor overactivity: An update on management options - Abstract June 13, 2013

Comparison between autonomic nervous system cardiovascular tests (ANSCVT) and lacrymal and or salivary secretion tests (LSST) in overactive bladder syndrome and voiding dysfunction - Abstract June 12, 2013

Analysis of female voiding dysfunction: A prospective, multi-center study - Abstract June 12, 2013

Intake of caffeinated, carbonated, or citrus beverage types and development of lower urinary tract symptoms in men and women - Abstract June 11, 2013

Meta-analysis of botulinum toxin a detrusor injections in the treatment of neurogenic detrusor overactivity following spinal cord injury - Abstract June 7, 2013

Reproducibility study of Overactive Bladder Symptom Score questionnaire and its response to treatment (RESORT) in Korean population with overactive bladder symptoms - Abstract June 6, 2013

Page 99 of 125